Nebraska
State Facts
Deaths or 49.7% of total overdose deaths involved opioids in 2024.¹
Claims or 3.67% of all Medicare Part D claims were for opioids in 2022 – an average of 45 per prescriber.²
Opioid Prescriptions were written for every 100 persons in Nebraska in 2023.³
Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴
Opioid Settlement Funds
National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.
Member & Endorser Footprint
2025 Introduced Relevant Legislation
LB 252
This legislation prohibits stricter coverage restrictions, higher cost-sharing, or formulary disadvantages for non-opioids compared to opioids, mandating immediate coverage for newly FDA-approved non-opioid drugs.
Introduced
03/17/2025Plan Impact
Medicaid & CommercialLR 219
This resolution proposes an interim study to examine access, effectiveness, and potential cost savings of non-opioid pain treatments within Medicaid, as well as evaluate initiatives and risks related to opioid use.
Introduced
05/15/2025Voices Letters
LB 252 Letter of Support
1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083
3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html
4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf